Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
Update on oral lichen planus
Expert Review of Dermatology, 10/14/09
Carrozzo M et al. – Oral lichen planus (OLP) is a relatively common chronic inflammatory disorder with a low risk of associated malignancy. A genetic predisposition linked to Th1 cytokine polymorphisms may predispose to the T–cell–mediated immunological response to an induced antigenic change that is supposed to cause OLP lesions. Amalgam restorations, hepatitis C virus and systemic medications may be etiologic factors.
Related Articles
Mucosal (oral and vulval) lichen planus in women: are angiotensin-converting enzyme inhibitors protective, and beta-blockers and non-steroidal anti-inflammatory drugs associated with the condition
Clinical and Experimental Dermatology, 11/02/09
Relevance Score: 79%%
Mucosal (oral and vulval) lichen planus in women: are angiotensin-converting enzyme inhibitors protective, and beta-blockers and non-steroidal anti-inflammatory drugs associated with the condition
Clinical and Experimental Dermatology, 10/30/09
Relevance Score: 79%%
Cyclosporine in the management of esophageal lichen planus
Canadian Journal of Gastroenterology, 10/12/09
Relevance Score: 79%%
Lichen planus in childhood: report of 100 cases
Clinical and Experimental Dermatology, 11/10/09
Relevance Score: 65%%
Management of Symptomatic Esophageal Involvement With Lichen Planus
Journal of Clinical Gastroenterology, 10/21/09
Relevance Score: 65%%
Today in Dermatology...keeping you current
Receive free subspecialty "5-minute updates" via email
Use of Oral N-Acetylcysteine for Protection of Melanocytic Nevi against UV-Induced Oxidative Stress: Towards a Novel Paradigm for Melanoma Chemoprevention
Clinical Cancer Research, 11/20/09
Iatrogenic Bullae Following Cupping Therapy
Journal of Alternative and Complementary Medicine, 11/20/09
BRAF V600E mutation and the tumour suppressor IGFBP7 in atypical genital naevi
British Journal of Dermatology, 11/20/09
Today in Hematology/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Normalisation of total body iron load with very intensive combined chelation reverses cardiac and endocrine complications of thalassaemia major
British Journal of Haematology, 11/20/09
Deciphering the molecular basis of venous thromboembolism: where are we and where should we go?
British Journal of Haematology, 11/20/09
Metronomic chemotherapy with daily, oral etoposide plus bevacizumab for recurrent malignant glioma: a phase II study
British Journal of Cancer, 11/20/09
Sponsor
Article Search
Sponsor


See Latest Articles


